Could a common cholesterol drug stop chronic migraine?
NCT ID NCT06485336
First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time
Summary
This study tests whether taking atorvastatin (a widely used cholesterol-lowering drug) every day for 12 weeks can reduce the number of migraine days in people with chronic migraine. About 300 adults aged 18–64 with chronic migraine will receive either atorvastatin or a placebo pill. The goal is to see if the drug prevents attacks better than placebo, with fewer side effects, and at a lower cost than current treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- atorvastatin 40 mg tablet taken daily for 84 days
- What this could lead to
- If it works, this could offer a new, affordable, and well-tolerated daily pill to prevent chronic migraine attacks.
- What could go wrong
- This is a Phase 2 trial, so results are not yet confirmed. Previous smaller studies showed promise, but the larger study may not replicate those benefits, and side effects are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC MIGRAINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Haukeland University Hospital
RECRUITINGBergen, Norway
Contact Email: •••••@•••••
-
Oslo University Hospital, Rikshospitalet
NOT_YET_RECRUITINGOslo, Norway
Contact Email: •••••@•••••
-
Oslo University Hospital, Ullevål
NOT_YET_RECRUITINGOslo, Norway
Contact Email: •••••@•••••
-
St. Olavs hospital
RECRUITINGTrondheim, Norway
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
-
University Hospital Northern Norway
RECRUITINGTromsø, Norway
Contact Email: •••••@•••••
-
University Hospital, Akershus
NOT_YET_RECRUITINGLørenskog, Norway
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a No-Fridge migraine shot replace botox?
- Migraine relief may sharpen the mind: study investigates cognitive benefits of preventive therapies
- New combo therapy for chronic migraine: atogepant plus botox under study
- Thousands to test new migraine meds in largest Real-Life study
- New migraine drug shows promise in Real-World study
- Virtual program aims to ease migraine suffering